Literature DB >> 10074149

HMG protein family members stimulate human immunodeficiency virus type 1 and avian sarcoma virus concerted DNA integration in vitro.

P Hindmarsh1, T Ridky, R Reeves, M Andrake, A M Skalka, J Leis.   

Abstract

We have reconstituted concerted human immunodeficiency virus type 1 (HIV-1) integration in vitro with specially designed mini-donor HIV-1 DNA, a supercoiled plasmid acceptor, purified bacterium-derived HIV-1 integrase (IN), and host HMG protein family members. This system is comparable to one previously described for avian sarcoma virus (ASV) (A. Aiyar et al., J. Virol. 70:3571-3580, 1996) that was stimulated by the presence of HMG-1. Sequence analyses of individual HIV-1 integrants showed loss of 2 bp from the ends of the donor DNA and almost exclusive 5-bp duplications of the acceptor DNA at the site of integration. All of the integrants sequenced were inserted into different sites in the acceptor. These are the features associated with integration of viral DNA in vivo. We have used the ASV and HIV-1 reconstituted systems to compare the mechanism of concerted DNA integration and examine the role of different HMG proteins in the reaction. Of the three HMG proteins examined, HMG-1, HMG-2, and HMG-I(Y), the products formed in the presence of HMG-I(Y) for both systems most closely match those observed in vivo. Further analysis of HMG-I(Y) mutants demonstrates that the stimulation of integration requires an HMG-I(Y) domain involved in DNA binding. While complexes containing HMG-I(Y), ASV IN, and donor DNA can be detected in gel shift experiments, coprecipitation experiments failed to demonstrate stable interactions between HMG-I(Y) and ASV IN or between HMG-I(Y) and HIV-1 IN.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10074149      PMCID: PMC104059     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  29 in total

1.  Concerted integration of viral DNA termini by purified avian myeloblastosis virus integrase.

Authors:  M L Fitzgerald; A C Vora; W G Zeh; D P Grandgenett
Journal:  J Virol       Date:  1992-11       Impact factor: 5.103

2.  Retroviral integrase functions as a multimer and can turn over catalytically.

Authors:  K S Jones; J Coleman; G W Merkel; T M Laue; A M Skalka
Journal:  J Biol Chem       Date:  1992-08-15       Impact factor: 5.157

Review 3.  Structural features of the HMG chromosomal proteins and their genes.

Authors:  M Bustin; D A Lehn; D Landsman
Journal:  Biochim Biophys Acta       Date:  1990-07-30

4.  A mutation at one end of Moloney murine leukemia virus DNA blocks cleavage of both ends by the viral integrase in vivo.

Authors:  J E Murphy; S P Goff
Journal:  J Virol       Date:  1992-08       Impact factor: 5.103

5.  The A.T-DNA-binding domain of mammalian high mobility group I chromosomal proteins. A novel peptide motif for recognizing DNA structure.

Authors:  R Reeves; M S Nissen
Journal:  J Biol Chem       Date:  1990-05-25       Impact factor: 5.157

6.  High-mobility-group 1 protein mediates DNA bending as determined by ring closures.

Authors:  P M Pil; C S Chow; S J Lippard
Journal:  Proc Natl Acad Sci U S A       Date:  1993-10-15       Impact factor: 11.205

Review 7.  HMG domain proteins: architectural elements in the assembly of nucleoprotein structures.

Authors:  R Grosschedl; K Giese; J Pagel
Journal:  Trends Genet       Date:  1994-03       Impact factor: 11.639

8.  Solution structure of a DNA-binding domain from HMG1.

Authors:  C M Read; P D Cary; C Crane-Robinson; P C Driscoll; D G Norman
Journal:  Nucleic Acids Res       Date:  1993-07-25       Impact factor: 16.971

Review 9.  A signature for the HMG-1 box DNA-binding proteins.

Authors:  D Landsman; M Bustin
Journal:  Bioessays       Date:  1993-08       Impact factor: 4.345

10.  Structure of the HMG box motif in the B-domain of HMG1.

Authors:  H M Weir; P J Kraulis; C S Hill; A R Raine; E D Laue; J O Thomas
Journal:  EMBO J       Date:  1993-04       Impact factor: 11.598

View more
  52 in total

Review 1.  Retroviral DNA integration.

Authors:  P Hindmarsh; J Leis
Journal:  Microbiol Mol Biol Rev       Date:  1999-12       Impact factor: 11.056

2.  DNase protection analysis of retrovirus integrase at the viral DNA ends for full-site integration in vitro.

Authors:  A Vora; D P Grandgenett
Journal:  J Virol       Date:  2001-04       Impact factor: 5.103

3.  Mechanism for specificity by HMG-1 in enhanceosome assembly.

Authors:  K B Ellwood; Y M Yen; R C Johnson; M Carey
Journal:  Mol Cell Biol       Date:  2000-06       Impact factor: 4.272

4.  Retroviral cDNA integration: stimulation by HMG I family proteins.

Authors:  L Li; K Yoder; M S Hansen; J Olvera; M D Miller; F D Bushman
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

5.  Inhibition of the integrases of human immunodeficiency viruses type 1 and type 2 by reverse transcriptases.

Authors:  Iris Oz; Orna Avidan; Amnon Hizi
Journal:  Biochem J       Date:  2002-02-01       Impact factor: 3.857

6.  The DNA-bending protein HMGB1 is a cellular cofactor of Sleeping Beauty transposition.

Authors:  Hatem Zayed; Zsuzsanna Izsvák; Dheeraj Khare; Udo Heinemann; Zoltán Ivics
Journal:  Nucleic Acids Res       Date:  2003-05-01       Impact factor: 16.971

7.  Correct integration of model substrates by Ty1 integrase.

Authors:  S P Moore; D J Garfinkel
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

8.  Cofactors for human immunodeficiency virus type 1 cDNA integration in vitro.

Authors:  Kui Gao; Robert J Gorelick; Donald G Johnson; Frederic Bushman
Journal:  J Virol       Date:  2003-01       Impact factor: 5.103

9.  Host factors that affect Ty3 retrotransposition in Saccharomyces cerevisiae.

Authors:  Michael Aye; Becky Irwin; Nadejda Beliakova-Bethell; Eric Chen; Jennifer Garrus; Suzanne Sandmeyer
Journal:  Genetics       Date:  2004-11       Impact factor: 4.562

10.  Differential multimerization of Moloney murine leukemia virus integrase purified under nondenaturing conditions.

Authors:  Rodrigo A Villanueva; Colleen B Jonsson; Jennifer Jones; Millie M Georgiadis; Monica J Roth
Journal:  Virology       Date:  2003-11-10       Impact factor: 3.616

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.